Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications
- PMID: 38037999
- DOI: 10.2174/0115680266273698231107110956
Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications
Abstract
Cellular senescence, an eternal condition of cell cycle arrest due to cellular stressors, is a sign of aging. Senescent cells (SCs) build up in tissues as they age, impairing their ability to repair themselves by causing the cell cycle to seize in progenitor cells and producing proinflammatory and the senescence-associated secretory phenotype (SASP) or matrix-degrading molecules. SASP aids in the emergence of several age-related diseases. Genetic studies have shown that removing SCs can delay aging and prolong life. Senolytics are small molecules designed to treat numerous age-related disorders can selectively kill SCs. A detailed discussion on senolytics and their potential as therapeutics to treat neuro-disorder and slow down aging is described herein. Emerging natural products, such as quercetin, dasatinib, fisetin, piperlongumine, and curcumin, have recently been reported to be effective senolytic agents, and some structurally modified analogue of these have also been explored for better selectivity and efficacy in animal models. These showed significant potential in clinical studies and could be developed as senolytic drugs in the future.
Keywords: Ageing; Cellular senescence; Natural products.; Senolytic agents; Senolytic targets.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Emerging senolytic agents derived from natural products.Mech Ageing Dev. 2019 Jul;181:1-6. doi: 10.1016/j.mad.2019.05.001. Epub 2019 May 8. Mech Ageing Dev. 2019. PMID: 31077707 Review.
-
A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases.J Food Biochem. 2022 Dec;46(12):e14471. doi: 10.1111/jfbc.14471. Epub 2022 Oct 21. J Food Biochem. 2022. PMID: 36268851 Review.
-
Exploring the role of senescence inducers and senotherapeutics as targets for anticancer natural products.Eur J Pharmacol. 2022 Aug 5;928:174991. doi: 10.1016/j.ejphar.2022.174991. Epub 2022 May 2. Eur J Pharmacol. 2022. PMID: 35513016 Review.
-
Cellular senescence of granulosa cells in the pathogenesis of polycystic ovary syndrome.Mol Hum Reprod. 2024 Apr 30;30(5):gaae015. doi: 10.1093/molehr/gaae015. Mol Hum Reprod. 2024. PMID: 38603629 Free PMC article.
-
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.EBioMedicine. 2019 Sep;47:446-456. doi: 10.1016/j.ebiom.2019.08.069. Epub 2019 Sep 18. EBioMedicine. 2019. PMID: 31542391 Free PMC article.
Cited by
-
In silico analysis of overall survival with YBX1 in male and female solid tumours.Sci Rep. 2024 Mar 27;14(1):7218. doi: 10.1038/s41598-024-57771-y. Sci Rep. 2024. PMID: 38538658 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources